SCHEMBL7375167

SCHEMBL7375167

CCCc1ccc(S(=O)(=O)C(N)(CN)C(=O)O)cc1

nearest known ligand 0.50

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CA2 P00918 6/20 0.50
ALDH1A1 P00352 4/20 0.41
CNR2 P34972 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
LMNA P02545 1/20 0.40
CA1 P00915 3/20 0.40
KDM4E B2RXH2 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.39
CA12 O43570 1/20 0.38
CA9 Q16790 1/20 0.38
FFAR4 Q5NUL3 1/20 0.38
HSD17B10 Q99714 1/20 0.37
HTR6 P50406 1/20 0.37
PLK1 P53350 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7372959 0.81 ALDH1A1 (0.45) CA2ALDH1A1LMNACA1L3MBTL1
SCHEMBL382142 0.79 SMN1; SMN2 (0.44) CA2SMN1; SMN2CA1CA12CA9
SCHEMBL7651608 0.79 SMN1; SMN2 (0.44) CA2SMN1; SMN2CA1CA12CA9
SCHEMBL9094518 0.78 CA2 (0.41) CA2ALDH1A1CA1CA12CA9
SCHEMBL7372099 0.78 NPC1 (0.45) CA2ALDH1A1CA1KDM4ECA12
Hydrochloric Acid SCHEMBL382912 0.78 SMN1; SMN2 (0.43) CA2SMN1; SMN2CA1CA12CA9
SCHEMBL7452279 0.78 CYP2C9 (0.42) CA2ALDH1A1CNR2SMN1; SMN2LMNA
SCHEMBL7378971 0.78 MMP13 (0.49) CA2ALDH1A1CA1
SCHEMBL8619624 0.76 KIF11 (0.44) CA2ALDH1A1CNR2CA1CA12
SCHEMBL16186194 0.72 CA2 (0.60) CA2ALDH1A1CNR2SMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0730590-A1 NOVEL ISOXAZOLINE AND ISOXAZOLE FIBRINOGEN RECEPTOR ANTAGONISTS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1996-09-11 EP claimed
WO-1995014683-A1 NOVEL ISOXAZOLINE AND ISOXAZOLE FIBRINOGEN RECEPTOR ANTAGONISTS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1995-06-01 WO claimed